Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
KAVI-ICR was pleased to host Prof. Rose Jepchumba Kosgei, newly appointed Associate Dean, Undergraduate Studies, Faculty of Health Sciences, during a courtesy visit to the Institute.
The visit brought together KAVI-ICR leadership and newly elected student leaders from the Faculty of Health Sciences and UNSA for an engaging discussion on mentorship, research exposure, academic growth and opportunities for continued collaboration.